WallStreetZenWallStreetZen

NASDAQ: PRE
Prenetics Global Ltd Earnings & Revenue

PRE earnings and revenue history

Current Revenue
$441.8M
Current Earnings
-$358.3M
Current Profit Margin
-81.1%

PRE Return on Equity

Insufficient data to display

Be the first to know when PRE announces earnings.

PRE Return on Assets

Current Company
-165.5%
Current Industry
6.3%
PRE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRE Return on Capital Employed

Current Company
-157.15%
Current Industry
10.8%

PRE vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRE$441.84MN/A-$358.34MN/AN/A
BVS$516.70M-$108.32M-$127.14M+27.05%N/A
LAB$109.19M-$174.48M-$178.68M+1.92%N/A
DMTK$14.69M-$110.81M-$114.51M+118.79%N/A
STIM$62.03M-$31.07M-$36.51M+5.94%N/A

PRE earnings dates

Next earnings date
Mar 1, 2023

Prenetics Global Earnings & Revenue FAQ

What were PRE's earnings last quarter?

Prenetics Global (NASDAQ: PRE) reported Q3 2022 earnings per share (EPS) of $1.24, up 145.76% year over year. Total Prenetics Global earnings for the quarter were -$14.90 million. In the same quarter last year, Prenetics Global's earnings per share (EPS) was -$2.71.

If you're new to stock investing, here's how to buy Prenetics Global stock.

What was PRE's earnings growth in the past year?

As of Q1 2023, Prenetics Global's earnings has grown year over year. Prenetics Global's earnings in the past year totalled -$358.34 million.

What is PRE's earnings date?

Prenetics Global's earnings date is Invalid Date. Add PRE to your watchlist to be reminded of PRE's next earnings announcement.

What was PRE's revenue last quarter?

Prenetics Global (NASDAQ: PRE) reported Q3 2022 revenue of $79.68 million up 6.73% year over year. In the same quarter last year, Prenetics Global's revenue was $74.66 million.

What was PRE's revenue growth in the past year?

As of Q1 2023, Prenetics Global's revenue has grown null year over year. Prenetics Global's revenue in the past year totalled $441.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.